Organization
European Organisation for Research and Treatment of Cancer (EORTC) Headquarters
3 abstracts
Abstract
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial.Org: University Hospital Zurich, EORTC - European Organisation for Research and Treatment of Cancer, Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands,
Abstract
Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive gastric (GC) and esophagogastric junction cancer (EGJC): First results of the EORTC 1203 INNOVATION study, in collaboration with the Korean Cancer Study Group, and the Dutch Upper GI Cancer group.Org: Grow School for Oncology and Reproduction, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, European Institute of Oncology - IRCCS, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea, Robert Debré University Hospital,
Abstract
Phase III study of adjuvant encorafenib plus binimetinib versus placebo in fully resected stage IIB/C BRAFV600-mutated melanoma: COLUMBUS-AD study design.Org: Melanoma Institute Australia, University Hospital (UKSH), Campus Kiel, Department of Dermatology, Kiel, Germany, University of Perugia, Ospedale Santa Maria della Misericordia, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, European Organization for Research and Treatment of Cancer (EORTC), Headquarters,